Albumin Market: By Type (Human Serum Albumin, Bovine Serum Albumin, and Recombinant Albumin), By Application (Drug Formulation and Vaccines, Life Sciences, Culture Media Ingredient, and Others), By Distribution Channel (Biopharmaceutical and Biotechnology Companies, Academic Research Institutes, and Others) and Geography    

Purchase Option

$ 4400
$ 6600
$ 8900

Albumin Market size was valued at USD 6,641 million in 2024, growing at a CAGR of 10.2% from 2024-2030. Albumins belong to the family of globular proteins. All the proteins present in the albumin family are water-soluble and moderately soluble in concentrated salt solutions. When subjected to heat, undergo denaturation. The albumins contribute 50% to 60% of the blood plasma proteins. The most common of them is serum albumins. The human serum albumin is the most abundant protein in human blood plasma. In March 2016, CSL Behring announced that the U.S. Food and Drug Administration (FDA) has approved IDELVION [Coagulation Factor IX (Recombinant), Albumin Fusion Protein], its novel, long-acting albumin fusion protein linking recombinant coagulation factor IX with recombinant albumin for the treatment of hemophilia B.

The global Albumin Market research report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland, and the Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezuela, and Rest of Latin America), and the Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of the Middle East and Africa).

Albumin Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

10.2%

Largest Market

APAC

Fastest Growing Market

Europe
Albumin Market Dynamics

Increase in the prevalence of liver disease is the major driving factor for the growth of the market. The increasing instances of conditions such as trauma and shock are anticipated to drive market revenue growth over the forecast period. Growing use of the albumin in the form of an excipient in the drug delivery and increasing acceptance of the drug among the healthcare fraternity is expected to enhance the growth of the market over the forecast period. However, availability of alternative therapies, dearth of the plasma, and scarcity of blood donors are likely to hinder the growth of the market over the forecast period.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Albumin Market Segmentation

By Type
  • Human Serum Albumin
  • Bovine Serum Albumin
  • Recombinant Albumin
By Application
  • Drug Formulation and Vaccines
  • Life Sciences
  • Culture Media Ingredient
  • Others
By Distribution Channel
  • Biopharmaceutical and Biotechnology companies
  • Academic research institutes
  • Others
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

The albumin market size was valued at USD 6,641 million in 2023

CSL Behring, Novozymes A/S, Thermo Fisher Scientific, Octapharma AG, MedxBio Pte. Ltd.

The Asia Pacific is the fastest-growing region for the albumin market

1. Executive Summary
2. Global Albumin Market Introduction
2.1. Global Albumin Market – Taxonomy
2.2. Global Albumin Market – Definitions
2.2.1. Type
2.2.2. Application
2.2.3. Distribution Channel
3. Global Albumin Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Albumin Market Dynamic Factors - Impact Analysis
3.6. Global Albumin Market – Competition Landscape
3.7. Epidemiology
4. Global Albumin Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Albumin Market, By Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1. Human Serum Albumin
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Bovine Serum Albumin
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Recombinant Albumin
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Albumin Market Forecast, By Application, 2019 - 2023 and Forecast, 2024 – 2030
6.1. Drug Formulation and Vaccines
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Life Sciences
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Culture Media Ingredient
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Albumin Market Forecast, By Distribution Channel, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1. Biopharmaceutical and Biotechnology companies
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Academic research institutes
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Albumin Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Albumin Market - Opportunity Analysis Index, By Type, By Application, By Distribution Channel, and Region, 2024 - 2030
9. North America Albumin Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Human Serum Albumin
9.1.2. Bovine Serum Albumin
9.1.3. Recombinant Albumin
9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Drug Formulation and Vaccines
9.2.2. Life Sciences
9.2.3. Culture Media Ingredient
9.2.4. Others
9.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Biopharmaceutical and Biotechnology companies
9.3.2. Academic research institutes
9.3.3. Others
9.4. Country Analysis 2016 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Albumin Market - Opportunity Analysis Index, By Type, By Application, By Distribution Channel, and Country, 2024 - 2030
9.6. North America Albumin Market Dynamics – Trends
10. Europe Albumin Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
10.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Human Serum Albumin
10.1.2. Bovine Serum Albumin
10.1.3. Recombinant Albumin
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Drug Formulation and Vaccines
10.2.2. Life Sciences
10.2.3. Culture Media Ingredient
10.2.4. Others
10.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Biopharmaceutical and Biotechnology companies
10.3.2. Academic research institutes
10.3.3. Others
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Albumin Market - Opportunity Analysis Index, By Type, By Application, By Distribution Channel, and Country, 2024 - 2030
10.6. Europe Albumin Market Dynamics – Trends
11. Asia-Pacific Albumin Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
11.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Human Serum Albumin
11.1.2. Bovine Serum Albumin
11.1.3. Recombinant Albumin
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Drug Formulation and Vaccines
11.2.2. Life Sciences
11.2.3. Culture Media Ingredient
11.2.4. Others
11.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Biopharmaceutical and Biotechnology companies
11.3.2. Academic research institutes
11.3.3. Others
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Albumin Market - Opportunity Analysis Index, By Type, By Application, By Distribution Channel, and Country, 2024 - 2030
11.6. Asia-Pacific Albumin Market Dynamics – Trends
12. Latin America Albumin Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
12.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Human Serum Albumin
12.1.2. Bovine Serum Albumin
12.1.3. Recombinant Albumin
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Drug Formulation and Vaccines
12.2.2. Life Sciences
12.2.3. Culture Media Ingredient
12.2.4. Others
12.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Biopharmaceutical and Biotechnology companies
12.3.2. Academic research institutes
12.3.3. Others
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Venezuela
12.4.5. Rest of Latin America
12.5. Latin America Albumin Market - Opportunity Analysis Index, By Type, By Application, By Distribution Channel, and Country, 2024 - 2030
12.6. Latin America Albumin Market Dynamics – Trends
13. Middle East and Africa Albumin Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
13.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Human Serum Albumin
13.1.2. Bovine Serum Albumin
13.1.3. Recombinant Albumin
13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Drug Formulation and Vaccines
13.2.2. Life Sciences
13.2.3. Culture Media Ingredient
13.2.4. Others
13.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Biopharmaceutical and Biotechnology companies
13.3.2. Academic research institutes
13.3.3. Others
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Albumin Market - Opportunity Analysis Index, By Type, By Application, By Distribution Channel, and Country, 2024 - 2030
13.6. MEA Albumin Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Thermo Fisher Scientific (U.S)
14.2.2. MedxBio Pte. Ltd. (Singapore)
14.2.3. China Biologic Products Inc. (China)
14.2.4. CSL Behring LLC (U.S)
14.2.5. Baxter International, Inc. (U.S)
14.2.6. Novozymes A/S. (Denmark)
14.2.7. Mitsubishi Tanabe Pharma (Japan)
14.2.8. Sigma-Aldrich Corporation (U.S)
14.2.9. Octapharma AG (Switzerland)
15. Research Methodology
16. Key Assumptions and Acronyms
  • Thermo Fisher Scientific (U.S)
  • MedxBio Pte. Ltd. (Singapore)
  • China Biologic Products Inc. (China)
  • CSL Behring LLC (U.S)
  • Baxter International, Inc. (U.S)
  • Novozymes A/S. (Denmark)
  • Mitsubishi Tanabe Pharma (Japan)
  • Sigma-Aldrich Corporation (U.S)
  • Octapharma AG (Switzerland)

Adjacent Markets